Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 129

1.

Statins in heart failure--With preserved and reduced ejection fraction. An update.

Tousoulis D, Oikonomou E, Siasos G, Stefanadis C.

Pharmacol Ther. 2014 Jan;141(1):79-91. doi: 10.1016/j.pharmthera.2013.09.001. Epub 2013 Sep 8. Review.

PMID:
24022031
2.

A novel paradigm for heart failure with preserved ejection fraction: comorbidities drive myocardial dysfunction and remodeling through coronary microvascular endothelial inflammation.

Paulus WJ, Tschöpe C.

J Am Coll Cardiol. 2013 Jul 23;62(4):263-71. doi: 10.1016/j.jacc.2013.02.092. Epub 2013 May 15. Review.

3.
4.

Heart failure with preserved ejection fraction: chronic low-intensity interval exercise training preserves myocardial O2 balance and diastolic function.

Marshall KD, Muller BN, Krenz M, Hanft LM, McDonald KS, Dellsperger KC, Emter CA.

J Appl Physiol (1985). 2013 Jan 1;114(1):131-47. doi: 10.1152/japplphysiol.01059.2012. Epub 2012 Oct 25.

5.

Atorvastatin improves left ventricular systolic function and serum markers of inflammation in nonischemic heart failure.

Sola S, Mir MQ, Lerakis S, Tandon N, Khan BV.

J Am Coll Cardiol. 2006 Jan 17;47(2):332-7. Epub 2005 Dec 20.

6.

Is targeting eNOS a key mechanistic insight of cardiovascular defensive potentials of statins?

Balakumar P, Kathuria S, Taneja G, Kalra S, Mahadevan N.

J Mol Cell Cardiol. 2012 Jan;52(1):83-92. doi: 10.1016/j.yjmcc.2011.09.014. Epub 2011 Sep 24. Review.

PMID:
21968328
7.

HMG-CoA reductase inhibitors in chronic heart failure: potential mechanisms of benefit and risk.

Laufs U, Custodis F, Böhm M.

Drugs. 2006;66(2):145-54. Review.

PMID:
16451090
8.

Beyond lipid-lowering: effects of statins on endothelial nitric oxide.

Laufs U.

Eur J Clin Pharmacol. 2003 Mar;58(11):719-31. Epub 2003 Feb 18. Review.

PMID:
12634978
9.

Atorvastatin therapy is associated with reduced levels of N-terminal prohormone brain natriuretic peptide and improved cardiac function in patients with heart failure.

Stypmann J, Schubert A, Welp H, Schulte H, Assmann G, Breithardt G, Nofer JR.

Clin Cardiol. 2008 Oct;31(10):478-81. doi: 10.1002/clc.20273.

10.

Should a statin be prescribed to every patient with heart failure?

Tsouli SG, Liberopoulos EN, Goudevenos JA, Mikhailidis DP, Elisaf MS.

Heart Fail Rev. 2008 Jun;13(2):211-25. Epub 2007 Aug 12. Review.

PMID:
17694432
11.

Pluripotential mechanisms of cardioprotection with HMG-CoA reductase inhibitor therapy.

Rosenson RS.

Am J Cardiovasc Drugs. 2001;1(6):411-20. Review.

PMID:
14728000
12.

Statin therapy for cardiac hypertrophy and heart failure.

Liao JK.

J Investig Med. 2004 May;52(4):248-53. Review.

13.

Statins do not significantly affect muscle sympathetic nerve activity in humans with nonischemic heart failure: a double-blind placebo-controlled trial.

Horwich TB, Middlekauff HR, Maclellan WR, Fonarow GC.

J Card Fail. 2011 Nov;17(11):879-86. doi: 10.1016/j.cardfail.2011.07.008. Epub 2011 Sep 3.

14.

Impact of the renin-angiotensin system on cardiac energy metabolism in heart failure.

Mori J, Zhang L, Oudit GY, Lopaschuk GD.

J Mol Cell Cardiol. 2013 Oct;63:98-106. doi: 10.1016/j.yjmcc.2013.07.010. Epub 2013 Jul 22. Review.

PMID:
23886814
15.

Mechanism of TNFalpha-induced IL-1alpha, IL-1beta and IL-6 expression in human cardiac fibroblasts: effects of statins and thiazolidinediones.

Turner NA, Mughal RS, Warburton P, O'Regan DJ, Ball SG, Porter KE.

Cardiovasc Res. 2007 Oct 1;76(1):81-90. Epub 2007 Jun 12.

16.

Preservation of NO production by statins in the treatment of heart failure.

Trochu JN, Mital S, Zhang Xp, Xu X, Ochoa M, Liao JK, Recchia FA, Hintze TH.

Cardiovasc Res. 2003 Nov 1;60(2):250-8.

17.

Statins activate peroxisome proliferator-activated receptor gamma through extracellular signal-regulated kinase 1/2 and p38 mitogen-activated protein kinase-dependent cyclooxygenase-2 expression in macrophages.

Yano M, Matsumura T, Senokuchi T, Ishii N, Murata Y, Taketa K, Motoshima H, Taguchi T, Sonoda K, Kukidome D, Takuwa Y, Kawada T, Brownlee M, Nishikawa T, Araki E.

Circ Res. 2007 May 25;100(10):1442-51. Epub 2007 Apr 26.

18.

[Should statins be part of the treatment of heart failure?].

Trochu JN.

Ann Cardiol Angeiol (Paris). 2004 Jul;53(4):209-16. Review. French.

PMID:
15369317
19.

An overview of the crosstalk between inflammatory processes and metabolic dysregulation during diabetic cardiomyopathy.

Palomer X, Salvadó L, Barroso E, Vázquez-Carrera M.

Int J Cardiol. 2013 Oct 9;168(4):3160-72. doi: 10.1016/j.ijcard.2013.07.150. Epub 2013 Aug 6. Review.

PMID:
23932046
20.

Statins and the myocardium.

Mital S, Liao JK.

Semin Vasc Med. 2004 Nov;4(4):377-84. Review.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk